10-Q Filing

Oruka Therapeutics, Inc. CIK: 907654 Q2 2011

Filing Information

Form Type	10-Q
Accession Number	`0001193125-11-223373`
Period End Date	20110630
Filing Date	20110815
Fiscal Year	2011
Fiscal Period	Q2
XBRL Instance	abio-20110630.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 64 Income Statement 78 Cash Flow Statement 103 Stockholders Equity 60

Balance Sheet 64 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$1.63	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$7.76M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$9.92M	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$7.46M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$7.03M	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Other current assets	`OtherAssetsCurrent`	$364.00K	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$137.00K	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Total current assets	`AssetsCurrent`	$7.16M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$7.83M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$490.00K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$690.00K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$264.00K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$304.00K	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	8.83M	shares	Point-in-time
Total assets	`Assets`	$8.16M	USD	Point-in-time
Total assets	`Assets`	$8.58M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	10.52M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	8.83M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	10.52M	shares	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$388.00K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$517.00K	USD	Point-in-time
Accrued compensation and employee benefits	`EmployeeRelatedLiabilitiesCurrent`	$175.00K	USD	Point-in-time
Accrued compensation and employee benefits	`EmployeeRelatedLiabilitiesCurrent`	$115.00K	USD	Point-in-time
Accrued expenses and other liabilities	`OtherLiabilitiesCurrent`	$339.00K	USD	Point-in-time
Accrued expenses and other liabilities	`OtherLiabilitiesCurrent`	$506.00K	USD	Point-in-time
Deferred rent, current portion	`DeferredRentCreditCurrent`	$121.00K	USD	Point-in-time
Deferred rent, current portion	`DeferredRentCreditCurrent`	$33.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.19M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.00M	USD	Point-in-time
Deferred rent, net of current portion	`DeferredRentCreditNoncurrent`	$32.00K	USD	Point-in-time
Deferred rent, net of current portion	`DeferredRentCreditNoncurrent`	$195.00K	USD	Point-in-time
Total liabilities	`Liabilities`	$1.39M	USD	Point-in-time
Total liabilities	`Liabilities`	$1.04M	USD	Point-in-time
Preferred stock, $0.001 par value; 5 million shares authorized; none issued and outstanding as of June 30, 2011 and December 31, 2010	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.001 par value; 5 million shares authorized; none issued and outstanding as of June 30, 2011 and December 31, 2010	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.001 par value; 100 million shares authorized; 10,515,707 and 8,834,535 shares issued and outstanding at June 30, 2011 and December 31, 2010, respectively	`CommonStockValue`	$11.00K	USD	Point-in-time
Common stock, $0.001 par value; 100 million shares authorized; 10,515,707 and 8,834,535 shares issued and outstanding at June 30, 2011 and December 31, 2010, respectively	`CommonStockValue`	$9.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$67.76M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$65.07M	USD	Point-in-time
Deficit accumulated during the development stage	`RetainedEarningsAccumulatedDeficit`	$-58.31M	USD	Point-in-time
Deficit accumulated during the development stage	`RetainedEarningsAccumulatedDeficit`	$-60.22M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$7.54M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$-678.00K	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$6.77M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$-19.69M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$7.41M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$-619.00K	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$-38.18M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$-115.00K	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$-5.74M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$8.16M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$8.58M	USD	Point-in-time

Income Statement 78 line items

Line Item	Tag	Value	Unit	Period
Research and development	`ResearchAndDevelopmentExpense`	$40.46M	USD	38 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$1.19M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$497.00K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$700.00K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$1.52M	USD	2 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$2.72M	USD	2 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$1.21M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$37.03M	USD	38 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$1.57M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$3.20M	USD	2 Qtrs
Merger transaction costs	`BusinessCombinationAcquisitionRelatedCosts`	$5.47M	USD	38 Qtrs
Restructuring expense, net	`RestructuringCharges`	$2.41M	USD	38 Qtrs
Loss on impairment of in-process research and development	`ImpairmentOfIntangibleAssetsExcludingGoodwill`	$6.00M	USD	38 Qtrs
Total costs and expenses	`OperatingExpenses`	$91.37M	USD	38 Qtrs
Total costs and expenses	`OperatingExpenses`	$4.72M	USD	2 Qtrs
Total costs and expenses	`OperatingExpenses`	$3.91M	USD	2 Qtrs
Total costs and expenses	`OperatingExpenses`	$1.70M	USD	1 Quarter
Total costs and expenses	`OperatingExpenses`	$2.27M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-4.72M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-1.70M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-2.27M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-3.91M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-91.37M	USD	38 Qtrs
Gain on bargain purchase	`BusinessCombinationBargainPurchaseGainRecognizedAmount`	$25.28M	USD	38 Qtrs
Gain on assignment of patent rights	`GainOnAssignmentOfPatentRights`	$2.00M	USD	38 Qtrs
Gain on assignment of patent rights	`GainOnAssignmentOfPatentRights`	$2.00M	USD	1 Quarter
Gain on assignment of patent rights	`GainOnAssignmentOfPatentRights`	$2.00M	USD	2 Qtrs
Interest and other income	`InvestmentIncomeInterestAndDividend`	$1.00K	USD	1 Quarter
Interest and other income	`InvestmentIncomeInterestAndDividend`	$2.02M	USD	38 Qtrs
Interest and other income	`InvestmentIncomeInterestAndDividend`	$1.00K	USD	2 Qtrs
Interest and other income	`InvestmentIncomeInterestAndDividend`	$2.00K	USD	2 Qtrs
Interest and other expense	`InterestExpenseDebt`	$7.00K	USD	2 Qtrs
Interest and other expense	`InterestExpenseDebt`	$2.00K	USD	1 Quarter
Interest and other expense	`InterestExpenseDebt`	$4.00K	USD	2 Qtrs
Interest and other expense	`InterestExpenseDebt`	$2.00K	USD	1 Quarter
Interest and other expense	`InterestExpenseDebt`	$441.00K	USD	38 Qtrs
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-62.50M	USD	38 Qtrs
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-2.27M	USD	1 Quarter
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-4.72M	USD	2 Qtrs
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$294.00K	USD	1 Quarter
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-1.91M	USD	2 Qtrs
Benefit from income taxes	`IncomeTaxExpenseBenefit`	$-2.28M	USD	38 Qtrs
Net income (loss)	`NetIncomeLoss`	$-1.46M	USD	Annual
Net income (loss)	`NetIncomeLoss`	$-116.00K	USD	8 Qtrs
Net income (loss)	`NetIncomeLoss`	$-1.91M	USD	2 Qtrs
Net income (loss)	`NetIncomeLoss`	$-13.99M	USD	Annual
Net income (loss)	`NetIncomeLoss`	$-19.43M	USD	Annual
Net income (loss)	`NetIncomeLoss`	$294.00K	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-2.27M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-511.00K	USD	Annual
Net income (loss)	`NetIncomeLoss`	$-4.72M	USD	2 Qtrs
Net income (loss)	`NetIncomeLoss`	$-8.42M	USD	Annual
Net income (loss)	`NetIncomeLoss`	$-5.24M	USD	Annual
Net income (loss)	`NetIncomeLoss`	$-60.22M	USD	38 Qtrs
Net income (loss)	`NetIncomeLoss`	$-9.14M	USD	Annual
Less: Accretion of redeemable convertible preferred stock	`AccretionOfRedeemableConvertiblePreferredStock`	$-245.00K	USD	38 Qtrs
Less: Deemed preferred stock dividend for additional common shares issuable under anti-dilution provisions	`PreferredStockDividendsAndOtherAdjustments`	$781.00K	USD	38 Qtrs
Net income (loss) available to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-61.25M	USD	38 Qtrs
Net income (loss) available to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-1.91M	USD	2 Qtrs
Net income (loss) available to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$294.00K	USD	1 Quarter
Net income (loss) available to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-2.27M	USD	1 Quarter
Net income (loss) available to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-4.72M	USD	2 Qtrs
Basic	`EarningsPerShareBasic`	$-0.58	USD	2 Qtrs
Basic	`EarningsPerShareBasic`	$-0.20	USD	2 Qtrs
Basic	`EarningsPerShareBasic`	$0.03	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$-0.26	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$-0.26	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$-0.20	USD	2 Qtrs
Diluted	`EarningsPerShareDiluted`	$0.03	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$-0.58	USD	2 Qtrs
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	10.13M	shares	1 Quarter
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	9.48M	shares	2 Qtrs
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	8.73M	shares	1 Quarter
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	8.19M	shares	2 Qtrs
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	10.25M	shares	1 Quarter
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	9.48M	shares	2 Qtrs
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	8.73M	shares	1 Quarter
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	8.19M	shares	2 Qtrs

Cash Flow Statement 103 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-1.46M	USD	Annual
Net loss	`NetIncomeLoss`	$-116.00K	USD	8 Qtrs
Net loss	`NetIncomeLoss`	$-1.91M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-13.99M	USD	Annual
Net loss	`NetIncomeLoss`	$-19.43M	USD	Annual
Net loss	`NetIncomeLoss`	$294.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-2.27M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-511.00K	USD	Annual
Net loss	`NetIncomeLoss`	$-4.72M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-8.42M	USD	Annual
Net loss	`NetIncomeLoss`	$-5.24M	USD	Annual
Net loss	`NetIncomeLoss`	$-60.22M	USD	38 Qtrs
Net loss	`NetIncomeLoss`	$-9.14M	USD	Annual
Gain on bargain purchase	`BusinessCombinationBargainPurchaseGainRecognizedAmount`	$25.28M	USD	38 Qtrs
Gain on patent rights assignment	`GainOnAssignmentOfPatentRights`	$2.00M	USD	38 Qtrs
Gain on patent rights assignment	`GainOnAssignmentOfPatentRights`	$2.00M	USD	1 Quarter
Gain on patent rights assignment	`GainOnAssignmentOfPatentRights`	$2.00M	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$171.00K	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$195.00K	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$1.33M	USD	38 Qtrs
Non-cash interest expense	`PaidInKindInterest`	$211.00K	USD	38 Qtrs
Share-based compensation	`ShareBasedCompensation`	$845.00K	USD	Annual
Share-based compensation	`ShareBasedCompensation`	$153.00K	USD	2 Qtrs
Share-based compensation	`ShareBasedCompensation`	$2.13M	USD	38 Qtrs
Share-based compensation	`ShareBasedCompensation`	$458.00K	USD	Annual
Share-based compensation	`ShareBasedCompensation`	$545.00K	USD	Annual
Share-based compensation	`ShareBasedCompensation`	$39.00K	USD	Annual
Share-based compensation	`ShareBasedCompensation`	$50.00K	USD	Annual
Share-based compensation	`ShareBasedCompensation`	$224.00K	USD	2 Qtrs
Issuance of warrants for lease termination	`IssuanceOfStockAndWarrantsForServicesOrClaims`	$377.00K	USD	38 Qtrs
Accretion of liabilities	`AccretionExpense`	$152.00K	USD	38 Qtrs
Impairment of property and equipment	`ImpairmentOfLongLivedAssetsHeldForUse`	$125.00K	USD	38 Qtrs
Impairment of in-process research and development	`ImpairmentOfIntangibleAssetsExcludingGoodwill`	$6.00M	USD	38 Qtrs
Write-off of deferred tax liability	`WriteOffOfDeferredTaxLiability`	$-2.28M	USD	38 Qtrs
Gain on marketable securities available for sale	`MarketableSecuritiesGainLoss`	$263.00K	USD	38 Qtrs
(Gain) loss from disposal of property and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	$-5.00K	USD	2 Qtrs
(Gain) loss from disposal of property and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	$-72.00K	USD	38 Qtrs
(Gain) loss from disposal of property and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	$4.00K	USD	2 Qtrs
Other, net	`OtherNoncashIncomeExpense`	$-267.00K	USD	38 Qtrs
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$12.00K	USD	2 Qtrs
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$81.00K	USD	2 Qtrs
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$-2.45M	USD	38 Qtrs
Other assets	`IncreaseDecreaseInOtherAssets`	$-7.21M	USD	38 Qtrs
Other assets	`IncreaseDecreaseInOtherAssets`	$-40.00K	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-254.00K	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-1.67M	USD	38 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$129.00K	USD	2 Qtrs
Accrued expenses and other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$-325.00K	USD	2 Qtrs
Accrued expenses and other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$-521.00K	USD	2 Qtrs
Accrued expenses and other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$-19.09M	USD	38 Qtrs
Deferred rent	`IncreaseDecreaseInDeferredCharges`	$55.00K	USD	2 Qtrs
Deferred rent	`IncreaseDecreaseInDeferredCharges`	$251.00K	USD	2 Qtrs
Deferred rent	`IncreaseDecreaseInDeferredCharges`	$-65.00K	USD	38 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-4.05M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-5.17M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-90.43M	USD	38 Qtrs
Cash received from Merger	`CashAcquiredFromAcquisition`	$30.39M	USD	38 Qtrs
Payment of deferred transaction costs	`PaymentOfDeferredTransactionCosts`	$-1.19M	USD	38 Qtrs
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$1.00K	USD	2 Qtrs
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$1.86M	USD	38 Qtrs
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$2.00K	USD	2 Qtrs
Proceeds from sale of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$15.37M	USD	38 Qtrs
Proceeds from sale of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$1.00K	USD	2 Qtrs
Proceeds from sale of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$6.00K	USD	2 Qtrs
Proceeds from sale of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$334.00K	USD	38 Qtrs
Proceeds from assignment of patent rights	`ProceedsFromSaleOfIntangibleAssets`	$2.00M	USD	38 Qtrs
Proceeds from assignment of patent rights	`ProceedsFromSaleOfIntangibleAssets`	$2.00M	USD	2 Qtrs
Net cash (used in) provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$2.00M	USD	2 Qtrs
Net cash (used in) provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$4.00K	USD	2 Qtrs
Net cash (used in) provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$45.05M	USD	38 Qtrs
Proceeds from issuance of convertible notes payable and related warrants for common stock	`ProceedsFromIssuanceOrSaleOfEquity`	$10.84M	USD	38 Qtrs
Proceeds from issuance of bank note payable	`ProceedsFromNotesPayable`	$4.00M	USD	38 Qtrs
Proceeds from stock subject to repurchase	`ProceedsFromStockSubjectToRepurchase`	$38.00K	USD	38 Qtrs
Proceeds from the issuance of preferred stock	`ProceedsFromIssuanceOfPreferredStockAndPreferenceStock`	$32.32M	USD	38 Qtrs
Proceeds from the issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$10.86M	USD	38 Qtrs
Proceeds from the issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$7.66M	USD	2 Qtrs
Proceeds from the issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$3.00M	USD	2 Qtrs
Repayment of principal on bank note payable	`RepaymentsOfNotesPayable`	$4.00M	USD	38 Qtrs
Repayment of principal on convertible notes payables	`RepaymentsOfConvertibleDebt`	$105.00K	USD	38 Qtrs
Repayment of principal on vendor finance agreement	`RepaymentOfPrincipalOnVendorFinanceAgreement`	$48.00K	USD	38 Qtrs
Repayment of principal on vendor finance agreement	`RepaymentOfPrincipalOnVendorFinanceAgreement`	$48.00K	USD	2 Qtrs
Net cash (used in) provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$7.32M	USD	2 Qtrs
Net cash (used in) provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$2.48M	USD	2 Qtrs
Net cash (used in) provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$52.85M	USD	38 Qtrs
Net (decrease) increase in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$438.00K	USD	2 Qtrs
Net (decrease) increase in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$7.46M	USD	38 Qtrs
Net (decrease) increase in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$2.15M	USD	2 Qtrs
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$7.76M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$9.92M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$7.46M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$7.03M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$7.76M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$9.92M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$7.46M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$7.03M	USD	Point-in-time
Interest paid	`InterestPaid`	$2.00K	USD	2 Qtrs
Interest paid	`InterestPaid`	$4.00K	USD	2 Qtrs
Interest paid	`InterestPaid`	$109.00K	USD	38 Qtrs
Accrued interest on notes payable converted to equity	`DebtInstrumentConvertibleInterestExpense`	$163.00K	USD	38 Qtrs
Warrant issued in connection with credit facility	`WarrantIssuedInConnectionWithCreditFacility`	$111.00K	USD	38 Qtrs
Accrued deferred transaction costs	`DeferredCosts`	$482.00K	USD	Point-in-time
Vendor finance agreement	`VendorFinanceAgreement`	$147.00K	USD	38 Qtrs
Vendor finance agreement	`VendorFinanceAgreement`	$147.00K	USD	2 Qtrs

Stockholders Equity 60 line items

Line Item	Tag	Value	Unit	Period
Issuance of common stock, per share	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Issuance of common stock, per share	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Issuance of preferred stock, per share	`PreferredStockParOrStatedValuePerShare`	$1.63	USD	Point-in-time
Issuance of preferred stock, per share	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Issuance of preferred stock, per share	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Beginning Balance, value	`StockholdersEquity`	$7.54M	USD	Point-in-time
Beginning Balance, value	`StockholdersEquity`	$-678.00K	USD	Point-in-time
Beginning Balance, value	`StockholdersEquity`	$6.77M	USD	Point-in-time
Beginning Balance, value	`StockholdersEquity`	$-19.69M	USD	Point-in-time
Beginning Balance, value	`StockholdersEquity`	$7.41M	USD	Point-in-time
Beginning Balance, value	`StockholdersEquity`	$-619.00K	USD	Point-in-time
Beginning Balance, value	`StockholdersEquity`	$-38.18M	USD	Point-in-time
Beginning Balance, value	`StockholdersEquity`	$-115.00K	USD	Point-in-time
Beginning Balance, value	`StockholdersEquity`	$-5.74M	USD	Point-in-time
Offering costs	`PreferredStockDiscountOnShares`	$-17.00K	USD	Point-in-time
Share-based compensation	`ShareBasedCompensation`	$845.00K	USD	Annual
Share-based compensation	`ShareBasedCompensation`	$153.00K	USD	2 Qtrs
Share-based compensation	`ShareBasedCompensation`	$2.13M	USD	38 Qtrs
Share-based compensation	`ShareBasedCompensation`	$458.00K	USD	Annual
Share-based compensation	`ShareBasedCompensation`	$545.00K	USD	Annual
Share-based compensation	`ShareBasedCompensation`	$39.00K	USD	Annual
Share-based compensation	`ShareBasedCompensation`	$50.00K	USD	Annual
Share-based compensation	`ShareBasedCompensation`	$224.00K	USD	2 Qtrs
Estimated fair value of warrants issued in connection with convertible notes payable	`AdjustmentToAdditionalPaidInCapitalEstimatedFairValueOfWarrantsIssuedInConnectionWithConvertibleNotesPayable`	$399.00K	USD	Annual
Issuance of common stock upon exercise of stock options, for cash, value	`StockIssuedDuringPeriodValueStockOptionsExercised`	$139.00K	USD	Annual
Issuance of common stock upon exercise of stock options, for cash, value	`StockIssuedDuringPeriodValueStockOptionsExercised`	$3.00K	USD	Annual
Issuance of common stock upon exercise of stock options, for cash, value	`StockIssuedDuringPeriodValueStockOptionsExercised`	$16.00K	USD	Annual
Issuance of common stock upon exercise of stock options, for cash, value	`StockIssuedDuringPeriodValueStockOptionsExercised`	$54.00K	USD	Annual
Issuance of common stock upon exercise of stock options, for cash, value	`StockIssuedDuringPeriodValueStockOptionsExercised`	$114.00K	USD	Annual
Net loss	`NetIncomeLoss`	$-1.46M	USD	Annual
Net loss	`NetIncomeLoss`	$-116.00K	USD	8 Qtrs
Net loss	`NetIncomeLoss`	$-1.91M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-13.99M	USD	Annual
Net loss	`NetIncomeLoss`	$-19.43M	USD	Annual
Net loss	`NetIncomeLoss`	$294.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-2.27M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-511.00K	USD	Annual
Net loss	`NetIncomeLoss`	$-4.72M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-8.42M	USD	Annual
Net loss	`NetIncomeLoss`	$-5.24M	USD	Annual
Net loss	`NetIncomeLoss`	$-60.22M	USD	38 Qtrs
Net loss	`NetIncomeLoss`	$-9.14M	USD	Annual
Deemed preferred stock dividend for additional common shares issuable under anti-dilution provision	`DividendsPreferredStockStock`	$-781.00K	USD	Annual
Conversion of preferred stock and convertible notes and related accrued interest, value	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	$33.78M	USD	Annual
Restricted stock release from restriction	`AdjustmentToAdditionalPaidInCapitalRestrictedStockReleaseFromRestriction`	$75.00K	USD	Annual
Conversion of warrants for preferred stock	`AdjustmentToAdditionalPaidInCapitalConversionOfWarrantsForPreferredStock`	$36.00K	USD	Annual
Merger with Nuvelo, Inc., value	`StockIssuedDuringPeriodValueAcquisitions`	$11.91M	USD	Annual
Issuance of common stock under employee stock purchase plan and upon vesting of restricted stock units, value	`StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan`	$2.00K	USD	Annual
Estimated fair value of warrants issued in connection with lease termination	`AdjustmentToAdditionalPaidInCapitalEstimatedFairValueOfWarrantsIssued`	$377.00K	USD	Annual
Issuance of common stock for cash, net of offering costs, value	`StockIssuedDuringPeriodValueNewIssues`	$2.53M	USD	2 Qtrs
Issuance of common stock for cash, net of offering costs, value	`StockIssuedDuringPeriodValueNewIssues`	$7.18M	USD	Annual
Ending Balance, value	`StockholdersEquity`	$7.54M	USD	Point-in-time
Ending Balance, value	`StockholdersEquity`	$-678.00K	USD	Point-in-time
Ending Balance, value	`StockholdersEquity`	$6.77M	USD	Point-in-time
Ending Balance, value	`StockholdersEquity`	$-19.69M	USD	Point-in-time
Ending Balance, value	`StockholdersEquity`	$7.41M	USD	Point-in-time
Ending Balance, value	`StockholdersEquity`	$-619.00K	USD	Point-in-time
Ending Balance, value	`StockholdersEquity`	$-38.18M	USD	Point-in-time
Ending Balance, value	`StockholdersEquity`	$-115.00K	USD	Point-in-time
Ending Balance, value	`StockholdersEquity`	$-5.74M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.